{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:18:12Z","timestamp":1764829092415,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ahj.2023.06.012","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T17:38:09Z","timestamp":1687714689000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial"],"prefix":"10.1016","volume":"265","author":[{"given":"Chen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiquan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.06.012_bib0001","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.06.012_bib0002","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.06.012_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.06.012_bib0004","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehz595","article-title":"16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction","volume":"41","author":"Thrane","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.06.012_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/eurheartj\/ehq375","article-title":"Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies","volume":"32","author":"Bueno","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.06.012_bib0006","first-page":"1082","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"70","author":"Ibanez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.ahj.2023.06.012_bib0007","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","article-title":"Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.06.012_bib0008","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.06.012_bib0009","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.CIR.86.6.1710","article-title":"A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction","volume":"86","author":"O'Neill","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.06.012_bib0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/hrt.82.4.426","article-title":"Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study","volume":"82","author":"Vermeer","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2023.06.012_bib0011","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0735-1097(99)00444-1","article-title":"A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial","volume":"34","author":"Ross","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.06.012_bib0012","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/euhj.1999.1993","article-title":"Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study","volume":"21","author":"Widimsky","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.06.012_bib0013","first-page":"445","volume":"62","author":"Wong","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.06.012_bib0014","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2005.04.042","article-title":"Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study)","volume":"46","author":"Le May","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.06.012_bib0015","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/eurheartj\/ehi432","article-title":"Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.06.012_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ahj.2005.04.005","volume":"150","author":"Investigators","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.06.012_bib0017","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(06)68147-6","article-title":"Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.06.012_bib0018","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2007.08.048","article-title":"Facilitated PCI by combination fibrinolysis or upstream tirofiban in acute ST-segment elevation myocardial infarction: results of the Alteplase and Tirofiban in Acute Myocardial Infarction (ATAMI) trial","volume":"130","author":"Peters","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2023.06.012_bib0019","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","article-title":"Facilitated PCI in patients with ST-elevation myocardial infarction","volume":"358","author":"Ellis","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.06.012_bib0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcin.2011.01.013","volume":"4","author":"Thiele","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.06.012_bib0021","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(06)68148-8","article-title":"Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials","volume":"367","author":"Keeley","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.06.012_bib0022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2021.10.005","article-title":"Thrombolytic and anticoagulant effects of a recombinant staphylokinase-hirudin fusion protein","volume":"208","author":"Ren","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.ahj.2023.06.012_bib0023","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11033-019-05167-x","article-title":"Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion","volume":"47","author":"Nedaeinia","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ahj.2023.06.012_bib0024","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings","volume":"312","author":"Group","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.06.012_bib0025","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/CIRCULATIONAHA.116.022603","article-title":"Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment-elevation myocardial infarction","volume":"134","author":"Carrick","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.06.012_bib0026","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(05)66516-6","article-title":"Multiplicity in randomised trials II: subgroup and interim analyses","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.06.012_bib0027","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/hc3101.093701","article-title":"Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials","volume":"104","author":"Stone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.06.012_bib0028","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1097\/MJT.0000000000000914","article-title":"Current perspectives in facilitated angioplasty","volume":"26","author":"Crisan","year":"2019","journal-title":"Am J Ther"},{"key":"10.1016\/j.ahj.2023.06.012_bib0029","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2174\/1389201019666180209121323","article-title":"Staphylokinase enzyme: an overview of structure, function and engineered forms","volume":"18","author":"Vakili","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ahj.2023.06.012_bib0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1745-7254.2007.00455.x","article-title":"Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits","volume":"28","author":"Li","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ahj.2023.06.012_bib0031","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCULATIONAHA.112.124248","article-title":"Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study","volume":"127","author":"Kohli","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.06.012_bib0032","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.06.012_bib0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323001680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323001680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:10:10Z","timestamp":1757571010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323001680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"alternative-id":["S0002870323001680"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.06.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}